AKBA Akebia Therapeutics, Inc.
Nasdaq · SEC CIK 1517022 · EDGAR
- Bought, last 12 months
- $86.6K 1 purchases by 1 insiders
- Sold, last 12 months
- $963.0K 7 sales by 6 insiders
- Filings on record
- 117 since 2021-09-02, latest 2026-08-10 16:08
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| Grund Nicholas | Chief Commercial Off | — | $117.9K |
| Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| Malabre Richard C | SVP, CAO | — | $68.8K |
| FRIESON RON | Dir | — | — |
| Wolf Myles | Dir | — | — |
| Smith Cynthia | Dir | — | — |
| ADAMS ADRIAN | Dir | — | — |
Transactions 131
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 16:08 | 2026-08-06 | AKBA | Butler John P. | CEO, Pres, Dir | M - OptEx | $0.63 | +350.0K | 3.72M | +10% | +$220.5K |
| T | 2026-07-01 16:34 | 2026-06-29 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | S - Sale | $1.11 | -56.0K | 616.6K | -8% | -$62.2K |
| D | 2026-06-22 16:24 | 2026-06-17 | AKBA | Wolf Myles | Dir | A - Grant | $0.00 | +35.7K | 169.1K | +27% | $0 |
| D | 2026-06-22 16:23 | 2026-06-17 | AKBA | Smith Cynthia | Dir | A - Grant | $0.00 | +35.7K | 196.6K | +22% | $0 |
| D | 2026-06-22 16:22 | 2026-06-17 | AKBA | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +35.7K | 197.4K | +22% | $0 |
| D | 2026-06-22 16:20 | 2026-06-17 | AKBA | FRIESON RON | Dir | A - Grant | $0.00 | +35.7K | 165.2K | +28% | $0 |
| D | 2026-06-22 16:10 | 2026-06-17 | AKBA | ZUMWALT LEANNE M | Dir | A - Grant | $0.00 | +35.7K | 145.1K | +33% | $0 |
| D | 2026-06-22 16:09 | 2026-06-17 | AKBA | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +35.7K | 236.2K | +18% | $0 |
| 2026-03-05 | 2026-03-04 | AKBA | Butler John P. | CEO, Pres, Dir | P - Purchase | $1.25 | +69.3K | 3.37M | +2% | +$86.6K | |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Rucci Carolyn M. | SVP, CLO | S - Sale | $1.39 | -69.8K | 588.4K | -11% | -$97.0K |
| T | 2026-02-04 | 2026-02-02 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | S - Sale | $1.39 | -35.0K | 672.6K | -5% | -$48.6K |
| T | 2026-02-04 | 2026-02-02 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $1.41 | +175.2K | 3.38M | +5% | +$247.1K |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $1.39 | -341.3K | 3.42M | -9% | -$474.4K |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.39 | -67.7K | 948.4K | -7% | -$94.0K |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Grund Nicholas | Chief Commercial Off | S - Sale | $1.39 | -84.8K | 561.8K | -13% | -$117.9K |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Malabre Richard C | SVP, CAO | S - Sale | $1.39 | -49.5K | 312.8K | -14% | -$68.8K |
| D | 2026-02-03 | 2026-01-30 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | A - Grant | $0.00 | +204.0K | 707.6K | +41% | $0 |
| D | 2026-02-03 | 2026-01-30 | AKBA | Rucci Carolyn M. | SVP, CLO | A - Grant | $0.00 | +190.0K | 658.1K | +41% | $0 |
| D | 2026-02-03 | 2026-01-30 | AKBA | Grund Nicholas | Chief Commercial Off | A - Grant | $0.00 | +204.0K | 646.6K | +46% | $0 |
| D | 2026-02-03 | 2026-01-30 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +204.0K | 1.02M | +25% | $0 |
| D | 2026-02-03 | 2026-01-30 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +743.0K | 3.46M | +27% | $0 |
| D | 2026-02-03 | 2026-01-30 | AKBA | Malabre Richard C | SVP, CAO | A - Grant | $0.00 | +79.0K | 348.9K | +29% | $0 |
| T | 2025-07-01 | 2025-06-30 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | S - Sale | $3.67 | -41.3K | 503.6K | -8% | -$151.6K |
| D | 2025-06-11 | 2025-06-10 | AKBA | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +35.7K | 200.5K | +22% | $0 |
| DT | 2025-06-11 | 2025-06-09 | AKBA | Malabre Richard C | SVP, CAO | S - Sale+OE | $4.01 | -15.0K | 266.9K | -5% | -$60.1K |
| DT | 2025-06-11 | 2025-06-09 | AKBA | Malabre Richard C | SVP, CAO | M - OptEx | $1.68 | +15.0K | 281.9K | +6% | +$25.2K |
| D | 2025-06-11 | 2025-06-10 | AKBA | Wolf Myles | Dir | A - Grant | $0.00 | +35.7K | 133.4K | +37% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | Smith Cynthia | Dir | A - Grant | $0.00 | +35.7K | 160.9K | +29% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | ZUMWALT LEANNE M | Dir | A - Grant | $0.00 | +35.7K | 109.4K | +48% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +35.7K | 152.8K | +30% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | FRIESON RON | Dir | A - Grant | $0.00 | +35.7K | 129.5K | +38% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +35.7K | 161.7K | +28% | $0 |
| T | 2025-06-05 | 2025-06-04 | AKBA | Malabre Richard C | SVP, CAO | S - Sale | $3.53 | -13.3K | 266.9K | -5% | -$47.1K |
| T | 2025-03-04 | 2025-03-03 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.83 | -7,144 | 809.1K | -0.9% | -$13.1K |
| T | 2025-03-04 | 2025-03-03 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $1.83 | -46.4K | 2.56M | -2% | -$84.9K |
| DMT | 2025-02-04 | 2025-02-03 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $2.10 | -144.2K | 2.60M | -5% | -$302.9K |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +701.0K | 2.75M | +34% | $0 |
| DMT | 2025-02-04 | 2025-02-03 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.10 | -50.5K | 816.2K | -6% | -$106.1K |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +194.9K | 866.7K | +29% | $0 |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Grund Nicholas | Chief Commercial Off | A - Grant | $0.00 | +194.9K | 498.2K | +64% | $0 |
| DT | 2025-02-04 | 2025-02-03 | AKBA | Grund Nicholas | Chief Commercial Off | S - Sale | $2.10 | -55.6K | 442.6K | -11% | -$116.8K |
| D | 2025-02-04 | 2025-01-31 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | A - Grant | $0.00 | +194.9K | 544.9K | +56% | $0 |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Malabre Richard C | SVP, CAO | A - Grant | $0.00 | +85.0K | 310.4K | +38% | $0 |
| DT | 2025-02-04 | 2025-02-03 | AKBA | Malabre Richard C | SVP, CAO | S - Sale | $2.10 | -30.2K | 280.2K | -10% | -$63.4K |
| D | 2025-01-22 | 2025-01-17 | AKBA | FRIESON RON | Dir | M - OptEx | $0.45 | +20.1K | 93.8K | +27% | +$9,045 |
| D | 2024-07-02 | 2024-06-28 | AKBA | Ostrowski Erik | SVP, CFO, CBO, Treas | A - Grant | $0.00 | +350.0K | 350.0K | New | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Smith Cynthia | Dir | A - Grant | $0.00 | +30.0K | 125.2K | +32% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Wolf Myles | Dir | A - Grant | $0.00 | +30.0K | 97.7K | +44% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +30.0K | 164.8K | +22% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +30.0K | 126.0K | +31% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | ZUMWALT LEANNE M | Dir | A - Grant | $0.00 | +30.0K | 73.7K | +69% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | FRIESON RON | Dir | A - Grant | $0.00 | +30.0K | 73.7K | +69% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +30.0K | 117.1K | +34% | $0 |
| T | 2024-05-14 | 2024-05-13 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $1.26 | -12.0K | 651.2K | -2% | -$15.1K |
| T | 2024-05-14 | 2024-05-13 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.26 | -34.8K | 672.1K | -5% | -$43.9K |
| 2024-05-09 | 2023-08-25 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.15 | -27.0K | 668.8K | -4% | -$31.0K | |
| 2024-03-01 | 2024-02-29 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.58 | -7,169 | 695.8K | -1% | -$11.3K | |
| 2024-03-01 | 2024-02-29 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $1.58 | -46.6K | 2.04M | -2% | -$73.6K | |
| 2024-03-01 | 2024-02-29 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $1.58 | -5,974 | 663.3K | -0.9% | -$9,439 | |
| 2024-03-01 | 2024-02-29 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.58 | -8,661 | 706.9K | -1% | -$13.7K | |
| 2024-02-29 | 2024-02-27 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $1.52 | -37.7K | 2.09M | -2% | -$57.4K | |
| 2024-02-29 | 2024-02-27 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.52 | -10.7K | 715.6K | -1% | -$16.3K | |
| T | 2024-02-29 | 2024-02-27 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.52 | -8,367 | 703.0K | -1% | -$12.7K |
| T | 2024-02-29 | 2024-02-27 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $1.52 | -7,411 | 669.2K | -1% | -$11.3K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Malabre Richard C | CAO | A - Grant | $0.00 | +223.9K | 223.9K | New | $0 |
| D | 2024-02-02 | 2024-01-31 | AKBA | Grund Nicholas | Chief Commercial Off | A - Grant | $0.00 | +303.3K | 303.3K | New | $0 |
| D | 2024-02-02 | 2024-01-31 | AKBA | Snow Ellen | SVP, CFO, Treas | A - Grant | $0.00 | +149.3K | 519.3K | +40% | $0 |
| D | 2024-02-02 | 2024-02-01 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $1.68 | -46.5K | 2.13M | -2% | -$78.1K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +603.5K | 2.18M | +38% | $0 |
| D | 2024-02-02 | 2024-01-31 | AKBA | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +149.3K | 676.6K | +28% | $0 |
| D | 2024-02-02 | 2024-02-01 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.68 | -24.3K | 711.4K | -3% | -$40.8K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +202.2K | 735.7K | +38% | $0 |
| D | 2024-02-02 | 2024-01-31 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +149.3K | 726.3K | +26% | $0 |
| D | 2023-08-01 | 2023-07-31 | AKBA | Snow Ellen | SVP, CFO, Treas | A - Grant | $0.00 | +370.0K | 370.0K | New | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +30.0K | 87.1K | +53% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +30.0K | 96.0K | +45% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | FRIESON RON | Dir | A - Grant | $0.00 | +30.0K | 43.7K | +219% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | Smith Cynthia | Dir | A - Grant | $0.00 | +30.0K | 95.2K | +46% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | Wolf Myles | Dir | A - Grant | $0.00 | +30.0K | 67.7K | +80% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | ZUMWALT LEANNE M | Dir | A - Grant | $0.00 | +30.0K | 43.7K | +219% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +30.0K | 134.8K | +29% | $0 |
| D | 2023-05-25 | 2023-05-24 | AKBA | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +200.0K | 587.5K | +52% | $0 |
| D | 2023-05-25 | 2023-05-25 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $1.22 | -63.2K | 524.3K | -11% | -$77.1K |
| D | 2023-05-25 | 2023-05-24 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +200.0K | 669.5K | +43% | $0 |
| D | 2023-05-25 | 2023-05-25 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.22 | -95.5K | 574.0K | -14% | -$116.5K |
| 2023-05-18 | 2023-05-16 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.07 | -63.6K | 530.5K | -11% | -$68.0K | |
| 2023-05-18 | 2023-05-16 | AKBA | Spellman David A | SVP, CFO, Treas | S - Sale | $1.07 | -63.6K | 446.5K | -12% | -$68.0K | |
| 2023-05-16 | 2023-05-12 | AKBA | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +100.0K | 387.5K | +35% | $0 | |
| 2023-05-16 | 2023-05-12 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +200.0K | 469.5K | +74% | $0 | |
| M | 2023-03-03 | 2023-03-01 | AKBA | Spellman David A | SVP, CFO, Treas | S - Sale | $0.88 | -7,210 | 510.1K | -1% | -$6,345 |
| M | 2023-03-03 | 2023-03-01 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $0.88 | -13.0K | 295.2K | -4% | -$11.5K |
| M | 2023-03-03 | 2023-03-01 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $0.88 | -91.9K | 1.57M | -6% | -$80.8K |
| M | 2023-03-03 | 2023-03-01 | AKBA | Dahan Michel | SVP, COO | S - Sale | $0.88 | -20.4K | 269.5K | -7% | -$18.0K |
| M | 2023-03-03 | 2023-03-01 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.88 | -14.1K | 601.6K | -2% | -$12.4K |
| 2023-03-01 | 2023-02-27 | AKBA | Spellman David A | SVP, CFO, Treas | S - Sale | $0.81 | -7,539 | 517.3K | -1% | -$6,107 | |
| 2023-03-01 | 2023-02-27 | AKBA | Dahan Michel | SVP, COO | S - Sale | $0.81 | -10.1K | 289.9K | -3% | -$8,173 | |
| 2023-03-01 | 2023-02-27 | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $0.81 | -6,677 | 300.6K | -2% | -$5,408 | |
| 2023-03-01 | 2023-02-27 | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $0.81 | -38.6K | 1.66M | -2% | -$31.3K | |
| 2023-03-01 | 2023-02-27 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.81 | -7,539 | 608.2K | -1% | -$6,107 | |
| D | 2023-02-02 | 2023-01-31 | AKBA | Spellman David A | SVP, CFO, Treas | A - Grant | $0.00 | +196.2K | 524.8K | +60% | $0 |
Purchase Sale Sale after option exercise All abbreviations